Ethyl Pyruvate Inhibits Hypoxic Pulmonary Vasoconstriction and Attenuates Pulmonary Artery Cytokine Expression

Ben M. Tsai, Tim Lahm, Eric D. Morrell, Paul R. Crisostomo, Jeffrey Poynter, Meijing Wang, Daniel R. Meldrum

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hypoxic pulmonary vasoconstriction is a common consequence of acute lung injury and may be mediated by increased local production of proinflammatory cytokines. Ethyl pyruvate is a novel anti-inflammatory agent that has been shown to down-regulate proinflammatory genes following hemorrhagic shock; however, its effects on hypoxic pulmonary vasoconstriction are unknown. We hypothesized that ethyl pyruvate would inhibit hypoxic pulmonary vasoconstriction and down-regulate pulmonary artery cytokine expression during hypoxia. To study this, isometric force displacement was measured in isolated rat pulmonary artery rings (n = 8/group) during hypoxia (95% N2/5% CO2) with or without prior ethyl pyruvate (10 mm) treatment. Following 60 min of hypoxia, pulmonary artery rings were analyzed for tumor necrosis factor-α and interleukin-1 mRNA via reverse transcriptase polymerase chain reaction. Ethyl pyruvate inhibited hypoxic pulmonary artery contraction (4.49 ± 2.32% versus 88.80 ± 5.68% hypoxia alone) and attenuated the hypoxic up-regulation of pulmonary artery tumor necrosis factor and interleukin-1 mRNA (P < 0.05). These data indicate that (1) hypoxia increases pulmonary artery vasoconstriction and proinflammatory cytokine gene expression; (2) ethyl pyruvate decreases hypoxic pulmonary vasoconstriction and down-regulates hypoxia-induced pulmonary artery proinflammatory cytokine gene expression; and (3) ethyl pyruvate may represent a novel therapeutic adjunct in the treatment of acute lung injury.

Original languageEnglish
Pages (from-to)130-134
Number of pages5
JournalJournal of Surgical Research
Volume145
Issue number1
DOIs
StatePublished - Mar 2008

Fingerprint

Vasoconstriction
Pulmonary Artery
Cytokines
Lung
Down-Regulation
Acute Lung Injury
Interleukin-1
Tumor Necrosis Factor-alpha
Gene Expression
Messenger RNA
Hemorrhagic Shock
ethyl pyruvate
Reverse Transcriptase Polymerase Chain Reaction
Hypoxia
Anti-Inflammatory Agents
Up-Regulation
Genes

Keywords

  • hypoxia
  • inflammation
  • pulmonary hypertension
  • signal transduction

ASJC Scopus subject areas

  • Surgery

Cite this

Ethyl Pyruvate Inhibits Hypoxic Pulmonary Vasoconstriction and Attenuates Pulmonary Artery Cytokine Expression. / Tsai, Ben M.; Lahm, Tim; Morrell, Eric D.; Crisostomo, Paul R.; Poynter, Jeffrey; Wang, Meijing; Meldrum, Daniel R.

In: Journal of Surgical Research, Vol. 145, No. 1, 03.2008, p. 130-134.

Research output: Contribution to journalArticle

Tsai, Ben M. ; Lahm, Tim ; Morrell, Eric D. ; Crisostomo, Paul R. ; Poynter, Jeffrey ; Wang, Meijing ; Meldrum, Daniel R. / Ethyl Pyruvate Inhibits Hypoxic Pulmonary Vasoconstriction and Attenuates Pulmonary Artery Cytokine Expression. In: Journal of Surgical Research. 2008 ; Vol. 145, No. 1. pp. 130-134.
@article{afa0dea71c5e4a22af1054381269aad9,
title = "Ethyl Pyruvate Inhibits Hypoxic Pulmonary Vasoconstriction and Attenuates Pulmonary Artery Cytokine Expression",
abstract = "Hypoxic pulmonary vasoconstriction is a common consequence of acute lung injury and may be mediated by increased local production of proinflammatory cytokines. Ethyl pyruvate is a novel anti-inflammatory agent that has been shown to down-regulate proinflammatory genes following hemorrhagic shock; however, its effects on hypoxic pulmonary vasoconstriction are unknown. We hypothesized that ethyl pyruvate would inhibit hypoxic pulmonary vasoconstriction and down-regulate pulmonary artery cytokine expression during hypoxia. To study this, isometric force displacement was measured in isolated rat pulmonary artery rings (n = 8/group) during hypoxia (95{\%} N2/5{\%} CO2) with or without prior ethyl pyruvate (10 mm) treatment. Following 60 min of hypoxia, pulmonary artery rings were analyzed for tumor necrosis factor-α and interleukin-1 mRNA via reverse transcriptase polymerase chain reaction. Ethyl pyruvate inhibited hypoxic pulmonary artery contraction (4.49 ± 2.32{\%} versus 88.80 ± 5.68{\%} hypoxia alone) and attenuated the hypoxic up-regulation of pulmonary artery tumor necrosis factor and interleukin-1 mRNA (P < 0.05). These data indicate that (1) hypoxia increases pulmonary artery vasoconstriction and proinflammatory cytokine gene expression; (2) ethyl pyruvate decreases hypoxic pulmonary vasoconstriction and down-regulates hypoxia-induced pulmonary artery proinflammatory cytokine gene expression; and (3) ethyl pyruvate may represent a novel therapeutic adjunct in the treatment of acute lung injury.",
keywords = "hypoxia, inflammation, pulmonary hypertension, signal transduction",
author = "Tsai, {Ben M.} and Tim Lahm and Morrell, {Eric D.} and Crisostomo, {Paul R.} and Jeffrey Poynter and Meijing Wang and Meldrum, {Daniel R.}",
year = "2008",
month = "3",
doi = "10.1016/j.jss.2007.03.067",
language = "English",
volume = "145",
pages = "130--134",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Ethyl Pyruvate Inhibits Hypoxic Pulmonary Vasoconstriction and Attenuates Pulmonary Artery Cytokine Expression

AU - Tsai, Ben M.

AU - Lahm, Tim

AU - Morrell, Eric D.

AU - Crisostomo, Paul R.

AU - Poynter, Jeffrey

AU - Wang, Meijing

AU - Meldrum, Daniel R.

PY - 2008/3

Y1 - 2008/3

N2 - Hypoxic pulmonary vasoconstriction is a common consequence of acute lung injury and may be mediated by increased local production of proinflammatory cytokines. Ethyl pyruvate is a novel anti-inflammatory agent that has been shown to down-regulate proinflammatory genes following hemorrhagic shock; however, its effects on hypoxic pulmonary vasoconstriction are unknown. We hypothesized that ethyl pyruvate would inhibit hypoxic pulmonary vasoconstriction and down-regulate pulmonary artery cytokine expression during hypoxia. To study this, isometric force displacement was measured in isolated rat pulmonary artery rings (n = 8/group) during hypoxia (95% N2/5% CO2) with or without prior ethyl pyruvate (10 mm) treatment. Following 60 min of hypoxia, pulmonary artery rings were analyzed for tumor necrosis factor-α and interleukin-1 mRNA via reverse transcriptase polymerase chain reaction. Ethyl pyruvate inhibited hypoxic pulmonary artery contraction (4.49 ± 2.32% versus 88.80 ± 5.68% hypoxia alone) and attenuated the hypoxic up-regulation of pulmonary artery tumor necrosis factor and interleukin-1 mRNA (P < 0.05). These data indicate that (1) hypoxia increases pulmonary artery vasoconstriction and proinflammatory cytokine gene expression; (2) ethyl pyruvate decreases hypoxic pulmonary vasoconstriction and down-regulates hypoxia-induced pulmonary artery proinflammatory cytokine gene expression; and (3) ethyl pyruvate may represent a novel therapeutic adjunct in the treatment of acute lung injury.

AB - Hypoxic pulmonary vasoconstriction is a common consequence of acute lung injury and may be mediated by increased local production of proinflammatory cytokines. Ethyl pyruvate is a novel anti-inflammatory agent that has been shown to down-regulate proinflammatory genes following hemorrhagic shock; however, its effects on hypoxic pulmonary vasoconstriction are unknown. We hypothesized that ethyl pyruvate would inhibit hypoxic pulmonary vasoconstriction and down-regulate pulmonary artery cytokine expression during hypoxia. To study this, isometric force displacement was measured in isolated rat pulmonary artery rings (n = 8/group) during hypoxia (95% N2/5% CO2) with or without prior ethyl pyruvate (10 mm) treatment. Following 60 min of hypoxia, pulmonary artery rings were analyzed for tumor necrosis factor-α and interleukin-1 mRNA via reverse transcriptase polymerase chain reaction. Ethyl pyruvate inhibited hypoxic pulmonary artery contraction (4.49 ± 2.32% versus 88.80 ± 5.68% hypoxia alone) and attenuated the hypoxic up-regulation of pulmonary artery tumor necrosis factor and interleukin-1 mRNA (P < 0.05). These data indicate that (1) hypoxia increases pulmonary artery vasoconstriction and proinflammatory cytokine gene expression; (2) ethyl pyruvate decreases hypoxic pulmonary vasoconstriction and down-regulates hypoxia-induced pulmonary artery proinflammatory cytokine gene expression; and (3) ethyl pyruvate may represent a novel therapeutic adjunct in the treatment of acute lung injury.

KW - hypoxia

KW - inflammation

KW - pulmonary hypertension

KW - signal transduction

UR - http://www.scopus.com/inward/record.url?scp=38949159715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949159715&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2007.03.067

DO - 10.1016/j.jss.2007.03.067

M3 - Article

C2 - 17574585

AN - SCOPUS:38949159715

VL - 145

SP - 130

EP - 134

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -